Loomis, Sayles & Company’s Aerie Pharmaceuticals AERI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,872,070	Closed	-$30M	–	946
2021 Q2	$30M	Sell	1,872,070 -38,030	-2%	-$652K	0.04%	251
2021 Q1	$34.1M	Sell	1,910,100 -6,143	-0.3%	-$106K	0.04%	210
2020 Q4	$25.9M	Sell	1,916,243 -10,948	-0.6%	-$132K	0.03%	230
2020 Q3	$22.7M	Buy	1,927,191 +745,413	+63%	+$9.08M	0.03%	210
2020 Q2	$17.4M	Buy	+1,181,778	New	+$17.5M	0.03%	242
2018 Q4	–	Sell	-371,215	Closed	-$22.8M	–	965
2018 Q3	$22.8M	Buy	371,215 +67,871	+22%	+$4.36M	0.04%	195
2018 Q2	$20.5M	Buy	303,344 +35,672	+13%	+$2M	0.04%	241
2018 Q1	$14.5M	Sell	267,672 -9,058	-3%	-$507K	0.03%	330
2017 Q4	$16.5M	Sell	276,730 -1,479	-0.5%	-$89.7K	0.03%	322
2017 Q3	$13.5M	Buy	+278,209	New	+$15.2M	0.03%	364